Terms: = Gastric cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
23 results:
1. System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer.
Kaviani E; Hajibabaie F; Abedpoor N; Safavi K; Ahmadi Z; Karimy A
Environ Res; 2023 Dec; 238(Pt 2):117168. PubMed ID: 37742751
[TBL] [Abstract] [Full Text] [Related]
2. IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
Lutz MS; Zekri L; Weßling L; Berchtold S; Heitmann JS; Lauer UM; Jung G; Salih HR
Front Immunol; 2023; 14():1163136. PubMed ID: 37122707
[TBL] [Abstract] [Full Text] [Related]
3. Association between oxidative stress, mitochondrial function of peripheral blood mononuclear cells and gastrointestinal cancers.
Liu W; Gao Y; Li H; Wang X; Jin M; Shen Z; Yang D; Zhang X; Wei Z; Chen Z; Li J
J Transl Med; 2023 Feb; 21(1):107. PubMed ID: 36765353
[TBL] [Abstract] [Full Text] [Related]
4. Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms.
Herman Mahečić D; Cigrovski Berković M; Zjačić-Rotkvić V; Čačev T; Kapitanović S; Ulamec M
Bosn J Basic Med Sci; 2020 Nov; 20(4):445-450. PubMed ID: 32156252
[TBL] [Abstract] [Full Text] [Related]
5. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract] [Full Text] [Related]
6. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
[TBL] [Abstract] [Full Text] [Related]
7. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells.
Xing R; Li L; Chen L; Gao Z; Wang H; Li W; Cui J; Tian G; Liang Q; Yu J; Sung JJ; Luo G; Gao H; Xu X; Yang H; Wang J; Zhang X; Wang JM; Huang J; Yu Y; Wang J; Lu Y
Oncogene; 2016 May; 35(20):2584-91. PubMed ID: 26364607
[TBL] [Abstract] [Full Text] [Related]
8. The effect of low-nitrogen and low-calorie parenteral nutrition combined with enteral nutrition on inflammatory cytokines and immune functions in patients with gastric cancer: a double blind placebo trial.
Li JH; Han L; Du TP; Guo MJ
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1345-50. PubMed ID: 25967707
[TBL] [Abstract] [Full Text] [Related]
9. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
Gao D; Li C; Xie X; Zhao P; Wei X; Sun W; Liu HC; Alexandrou AT; Jones J; Zhao R; Li JJ
PLoS One; 2014; 9(4):e93886. PubMed ID: 24699863
[TBL] [Abstract] [Full Text] [Related]
10. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative il-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
[TBL] [Abstract] [Full Text] [Related]
12. [Effect of early intestinal dripping of jianpi tongli Chinese herbs on serum level il-2, sil-2R and IL-12 in patients with gastric cancer after operation].
Yu QS; Liu Y; Hou Y; Zhang F; Yi W; Wang X; Shuai J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):710-3. PubMed ID: 16152828
[TBL] [Abstract] [Full Text] [Related]
13. Laparoscopic-assisted intraperitoneal chemotherapy for patients with scirrhous gastric cancer.
Ikeguchi M; Matsumoto S; Yoshioka S; Murakami D; Kanaji S; Ohro S; Yamaguchi K; Saito H; Tatebe S; Kondo A; Tsujitani S; Kaibara N
Chemotherapy; 2005 Mar; 51(1):15-20. PubMed ID: 15722628
[TBL] [Abstract] [Full Text] [Related]
14. Biological, histological, and clinical impact of preoperative il-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract] [Full Text] [Related]
15. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
[TBL] [Abstract] [Full Text] [Related]
16. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.
Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A
Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579
[TBL] [Abstract] [Full Text] [Related]
17. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract] [Full Text] [Related]
18. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
[TBL] [Abstract] [Full Text] [Related]
19. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer.
Forones NM; Mandowsky SV; Lourenço LG
Hepatogastroenterology; 2001; 48(40):1199-201. PubMed ID: 11490833
[TBL] [Abstract] [Full Text] [Related]
20. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer.
Maeta M; Saito H; Katano K; Kondo A; Tsujitani S; Makino M; Ikeguchi M; Kaibara N
Int J Mol Med; 1998 Jan; 1(1):113-6. PubMed ID: 9852207
[TBL] [Abstract] [Full Text] [Related]
[Next]
